Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited has announced the cessation of 415,000 options due to their expiry on June 1, 2024, without being exercised or converted. This notification is provided as a formal disclosure to the market and represents a new announcement for the investors and stakeholders of the company.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.